Results 51 to 60 of about 50,215 (193)

Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant‐Ineligible Newly Diagnosed Myeloma: An Australian Real‐World, Multicenter Study

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
RVD with weekly bortezomib dosing in real‐world newly diagnosed transplant‐ineligible myeloma shows comparable efficacy and reduced toxicity compared to twice‐weekly trial protocols. ABSTRACT Background Lenalidomide, bortezomib, and dexamethasone (RVD) remains a standard of care regimen for newly diagnosed multiple myeloma in centers without access to ...
Samantha Kurniawan   +17 more
wiley   +1 more source

Severe Hyponatremia as the Initial Sign Preceding Guillain-Barré Syndrome, an Acute Inflammatory Demyelinating Polyneuropathy: A Case Report

open access: yesCase Reports in Neurological Medicine, 2013
Guillain-Barré syndrome is an immune-mediated polyneuropathy that frequently presents with progressive muscle weakness. Hyponatremia has recently been described as a feature of this condition, generally appearing over the course of the illness and ...
Benjamin Kloesel, LaTonya J. Hickson
doaj   +1 more source

Clinical Burden of Symptomatic HEV‐3 Infection in Southern Spain

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Clinical burden of symptomatic HEV‐3 infection in southern Spain. Between 2022 and 2025, 1124 patients with acute hepatitis, defined as ALT ≥ 3 times the upper limit of normal and negative screening for HAV, HBV, HCV, EBV and CMV, were evaluated in Andalusia.
María Casares‐Jimenez   +14 more
wiley   +1 more source

Proteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survival

open access: yesBrain Pathology, EarlyView.
Untargeted multiomic profiling of cerebrospinal fluid reveals that proteomic, but not lipidomic, signatures robustly distinguish ALS patients from controls and stratify individuals by survival, highlighting marked molecular differences between short survival and long survival disease.
Sergio Roca‐Pereira   +19 more
wiley   +1 more source

Síndrome de Guillain-Barré, reporte de un caso en un lactante mayor y revisión de la literatura

open access: yes, 2017
Introduction: The Guillain-Barré syndrome is an acute inflammatory polyradiculoneuropathy that is characterized by a progressive pattern; within its possible etiology, there is an association between histories of viral and/or bacterial infection and
Edison Rodríguez-Coy Rodríguez-Coy   +5 more
core   +1 more source

Regional variation of Guillain-Barré syndrome

open access: yes, 2018
© 2018 The Author(s). Guillain-Barré syndrome is a heterogeneous disorder regarding the clinical presentation, electrophysiological subtype and outcome.
Barroso, Fabio A.   +30 more
core   +2 more sources

A rapid onset of Guillain–Barre syndrome following spinal anesthesia for knee arthroscopy: a case report

open access: yesJournal of Medical Case Reports
Background Guillain–Barré syndrome, a rare autoimmune polyneuropathy, typically follows infections and rarely surgical procedures. Post-surgical Guillain–Barré syndrome is an uncommon subset with significant clinical implications.
Amin Ahmed Kapadia   +4 more
doaj   +1 more source

S3 guideline diagnostics and therapy in alopecia areata – Part 2: Therapy, psychosocial and cosmetic support

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary This second part of the S3 guideline on the diagnosis and treatment of alopecia areata (AA), presents key recommendations on topical and systemic therapy, quality of life and support services. The first part of the guideline, published separately, covers the definition and content of epidemiology and diagnosis as well as comorbidities, risk and
Ulrike Blume‐Peytavi   +13 more
wiley   +1 more source

Síndrome de guillain-barré pós cirurgia bariátrica: relato de caso e revisão de literatura

open access: yes, 2020
Guillain-Barré Syndrome is an inflammatory polyneuroradiculopathy, being the most prevalent cause of acute flaccid paralysis, with an annual incidence of 1 to 2 cases per 100,000 people per year. It is clinically characterized, in its most common form,
Rodrigues, Helder Barbosa
core  

Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort

open access: yes, 2020
Background: Guillain-Barré syndrome is the most common cause of acute flaccid paresis in childhood. Few validated large-scale population-based data are available concerning pediatric Guillain-Barré syndrome, including incidence, risk factors, and initial
Levison, Lotte Sahin   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy